Core Viewpoint - The phenomenon of the overuse of facial fillers in the medical beauty industry is a long-standing issue that remains in a gray area, with significant risks associated with improper application and unregulated practices [1][3]. Industry Overview - The non-surgical light medical beauty market in China, represented by injection and photonic treatments, has been growing steadily, projected to account for 64% of the entire medical beauty market by 2030 [1]. - The market has transitioned from a phase characterized by illegal practices such as "black medical beauty" to a new phase where new products and technologies are frequently misapplied [1][4]. Regulatory Environment - Regulatory bodies have begun to take action against the misuse of orthopedic materials in medical beauty, particularly focusing on the use of hydroxyapatite products beyond their approved indications [4]. - Multiple regions, including Beijing and Shenzhen, have conducted inspections and required medical beauty institutions to self-check their use of hydroxyapatite [4]. Product Usage and Risks - Hyaluronic acid dominates the global skin filler market with a 77% share, while hydroxyapatite, originally used in orthopedics and dentistry, holds a 7% share [3]. - Despite the approval of new products like hydroxyapatite for facial filling, the overuse of facial fillers remains a significant risk, often leading to irreversible consequences for patients [3][5]. Market Dynamics - The emergence of new injection materials is disrupting the traditional dominance of botulinum toxin and hyaluronic acid in the medical beauty filler market [5]. - The market is still heavily influenced by commercial interests, with some institutions prioritizing specific products over medical necessity [5]. Training and Expertise - There is a notable shortage of qualified aesthetic doctors in China, with only 0.2 plastic surgeons per 100,000 people compared to 2.3 in the U.S. and 2.5 in Japan, which exacerbates the risks associated with medical beauty procedures [10]. - The lack of professional training and the rapid turnover of aesthetic doctors contribute to the potential for medical risks in the industry [10]. Future Trends - As more public hospitals enter the light medical beauty market, the share of large medical beauty institutions is increasing, while smaller clinics face closure due to regulatory and operational pressures [10]. - The industry is expected to move towards more standardized processes for the application of medical beauty products, reducing the frequency of overuse incidents [10].
骨科材料“超范围”填充面部,医美超适应证风险频发,如何解
Di Yi Cai Jing·2025-12-17 12:52